Overview
The MOSI System is a research decision-support calculator for obesity severity staging, therapeutic weight-loss target estimation, and procedure-specific bariatric outcome estimates.
Affiliated Centers
AI in Surgical Technology & Augmentation Research (A‑STAR) Lab
Surgical innovation, artificial intelligence, and clinical decision-support research.
Mayo Clinic
Academic medical center and clinical research environment supporting bariatric surgery innovation.
The MOSI System was developed as a research decision-support platform affiliated with the AI in Surgical Technology & Augmentation Research (A-STAR) Lab and Mayo Clinic.
Development and affiliation
Developed by the AI in Surgical Technology & Augmentation Research (A-STAR) Lab, Mayo Clinic.
The platform was developed as a research platform to support bariatric surgery phenotyping, clinical communication, and prospective validation.
How the calculator works
- BMI determines the M class.
- Selected metabolic and organ conditions determine the O score.
- End-organ or systemic disease determines the Si level.
- M class, O score, and Si level combine to generate the MOSI stage.
- Tier A applies when no Tier B, C, or D target-defining feature is selected.
- GERD/reflux is collected as a procedure-planning consideration; it does not contribute to O score, assign Tier B, or change the required weight-loss target.
- Bariatric procedure outcome estimates display SG, RYGB, and exploratory BPD-DS/SADI-S values when exact estimates are available.
Algorithm definitions
M class
M1: BMI 30.0–34.9; M2: 35.0–39.9; M3: 40.0–44.9; M4: 45.0–49.9; M5: BMI ≥50.0.
O score
One point each for hypertension, dysglycemia, obstructive sleep apnea, and hyperlipidemia. IFG and T2DM count once as one dysglycemia component. GERD/reflux is not part of O score.
Si level
Si0: no end-organ involvement. Si1: diabetic microvascular/end-organ disease. Si2: major organ dysfunction. Si3: dialysis-dependent renal failure or solid-organ transplant recipient status.
MOSI stage
- Stage IV: Si3.
- Stage IV-A: transplant without dialysis.
- Stage IV-B: dialysis, with or without transplant.
- Stage III: Si2, or Si1 with M ≥4 or O ≥3.
- Stage I: Si0 with M ≤2 and O ≤1.
- Stage II: all remaining combinations.
Weight-loss target tiers
Tier A: foundational weight-loss target, ≥7.5% TWL. It applies when no Tier B, C, or D target-defining feature is selected. Tier B: ≥15% TWL. Tier C: ≥25% TWL. Tier D: ≥30% TWL. Highest qualifying tier wins.
Procedure planning
GERD/reflux may inform discussion of bypass when options are otherwise clinically similar, but it does not change MOSI stage, O score, target tier, or required weight-loss target. Procedure choice requires bariatric surgeon judgment.
Bariatric procedure outcome estimates
SG, RYGB, and exploratory BPD-DS/SADI-S probabilities are shown at 12 and 60 months when exact values are available. Missing cells remain N/A.
In methodology documentation, MOSI-S refers to severity stage, MOSI-T to therapeutic target, and MOSI-D to decision-support estimates.
Study data summary
Staged cohortn = 3,192
12-month cohortn = 2,939
Primary endpointTWL ≥20%
Stage I191 · 91.6%
Stage II1,542 · 87.4%
Stage III1,297 · 80.3%
Stage IV162 · 58.5%
Stage IV-A86
Stage IV-B76
AUC0.761
AUC + age + sex0.789
DeLongp = 0.049 / 0.49
Tier A248
Tier B654
Tier C1,549
Tier D488
Stage distribution: Stage I 191; Stage II 1,542; Stage III 1,297; Stage IV 162; Stage IV-A 86; Stage IV-B 76. 12-month TWL ≥20% success: Stage I 91.6%; Stage II 87.4%; Stage III 80.3%; Stage IV 58.5%.
MOSI + Procedure AUC: 0.761. MOSI + Procedure + Age + Sex AUC: 0.789. DeLong comparisons: MOSI+Procedure vs BMI+Procedure p = 0.049; MOSI+Procedure vs EOSS-proxy+Procedure p = 0.49. Target-tier distribution: Tier A 248; Tier B 654; Tier C 1,549; Tier D 488.
Limitations
- Retrospective single-center derivation.
- Observational procedure comparisons and possible procedure-selection bias.
- Smaller Stage IV and BPD-DS/SADI-S subgroups.
- 60-month attrition.
- Research decision-support only; not a medical device and not a substitute for clinician judgment.
Although age and sex were included in a fully adjusted performance model, the active calculator displays stage- and procedure-based retrospective estimates rather than individualized coefficient-based predictions. The active estimate display focuses on 12-month and 60-month horizons. Entered features are interpreted as present when selected; unselected features are treated as absent for this calculator.
This static calculator runs in the browser and does not store or submit entered values.